BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals

Archive ouverte

Saade, Carla | Bruel, Timothée | Vrignaud, Lou-Léna | Killian, Martin | Drouillard, Annabelle | Barateau, Véronique | Espi, Maxime | Mariano, Natacha | Mignon, Charlotte | Bruyère, Lily | Khoryati, Liliane | Bolland, William Henry | Schwartz, Olivier | Lina, Bruno | Valette, Martine | Thaunat, Olivier | Fassier, Jean-Baptiste | Pozzetto, Bruno | Paul, Stéphane | Walzer, Thierry | Trouillet-Assant, Sophie

Edité par CCSD ; Elsevier -

International audience. Immune memory is influenced by the frequency and type of antigenic challenges. Here, we performed a cross-sectional comparison of immune parameters following a BA.breakthrough infection in individuals with prior hybrid immunity (conferred by infection and vaccination) versus those solely vaccinated in a cohort of health care workers in Lyon, France. The results showed higher levels of serum anti-RBD antibodies and neutralizing antibodies against BA.1 post-infection in the vaccine-only group. Individuals in this group also showed a decrease in memory B cells against the ancestral strain but an increase in those specific and cross-reactive to BA.1, suggesting a more limited immune imprinting. Conversely, hybrid immunity prevents the decrease in ADCC response, possibly by limiting IgG4 class-switching, and enhanced anti-N responses post-infection. This highlights that BA.1 breakthrough infection induces different immune responses depending on prior history of vaccination and infection, which should be considered for further vaccination guidelines.

Suggestions

Du même auteur

Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination

Archive ouverte | Barateau, Véronique | CCSD

The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of how these parameters imprin...

Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination

Archive ouverte | Pozzetto, Bruno | CCSD

Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine1,2, European health authorities recommended that patients under the age of 55?years who received one dose of ChAdOx1-S-nCoV-19 receive a second dose o...

Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2

Archive ouverte | Saade, Carla | CCSD

International audience. SARS-CoV-2 mutations appeared recently and can lead to conformational changes in the spike protein and probably induce modifications in antigenicity. We assessed the neutralizing capacity of ...

Chargement des enrichissements...